IQSM
NYLI Candriam U.S. Mid Cap Equity ETF
SMB
Adj. R2
0.921
Rel. Sharpe
0.443
Mkt beta
1.06
AUM
US$312M
MER
0.15%
Valuation
108
ETF comparison
Verified factor-similar pair
IQSM vs PRFZ
These two ETFs pass the same FF6 US similarity lane: US-listed equity ETFs, same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
Similarity score
84
Verified similar
Score blends exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
SMB
Adj. R2
0.976
Rel. Sharpe
0.916
Mkt beta
1.02
AUM
US$2.7B
MER
0.34%
Valuation
141
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff -0.37
HML
diff +0.03
RMW
diff +0.08
CMA
diff +0.08
UMD
diff +0.03
Why This Pair Matches
Exposure level
82
Exposure shape
97
Mkt beta diff
0.04
Rel. Sharpe diff
0.473
This comparison focuses on measured factor exposure, not a qualitative review of each fund's portfolio-construction process. Backtested relative Sharpe is included as a secondary signal, while we continue refining a comparison metric that separates factor payoff from alpha. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.